Evidence map›Paper›PMID 38526147›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Noninvasive Tracking of Embryonic Cardiac Dynamics and Development with Volumetric Optoacoustic Spectroscopy.

Maryam Hatami, Ali Özbek, Xosé Luís Deán-Ben, Jessica Gutierrez, Alexander Schill, Daniel Razansky, Kirill V Larin

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maryam HatamiDepartment of Biomedical Engineering, University of Houston, Houston, TX, 77004, USA.ORCID 0000-0002-4165-3214
Ali ÖzbekInstitute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, 8057, Switzerland.
Xosé Luís Deán-BenInstitute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, 8057, Switzerland.
Jessica GutierrezDepartment of Biomedical Engineering, University of Houston, Houston, TX, 77004, USA.
Alexander SchillDepartment of Biomedical Engineering, University of Houston, Houston, TX, 77004, USA.
Daniel RazanskyInstitute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, 8057, Switzerland.
Kirill V LarinDepartment of Biomedical Engineering, University of Houston, Houston, TX, 77004, USA.ORCID 0000-0002-5532-5027
University of Houston · USUniversity of Zurich · CHBaylor College of Medicine · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI LAURA J. FRISHMAN · 1988 to 2026
$16.4M
Optical Coherence Tomography to Study Effect of Poly - Drug Exposure on Fetal Brain DevelopmentR01HD086765 · NICHD · UNIVERSITY OF HOUSTON · PI Kirill V Larin, Irina Larina · 2016 to 2026
$5.0M
Structural and Molecular Phenotyping of Embryonic Development through Multi-Modal Optical ImagingR01HL146745 · NHLBI · UNIVERSITY OF HOUSTON · PI MAYERICH, DAVID · 2019 to 2023
$3.7M
Prenatal alcohol/cannabinoid co-exposures and fetal brain developmentR01AA028406 · NIAAA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI LARIN, KIRILL V, MIRANDA, RAJESH C · 2020 to 2024
$2.6M
In vivo investigation of cilia function in the fallopian tubeR01HD112102 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Irina Larina · 2024 to 2026
$1.8M
NEI NIH HHS P30 EY007551NHLBI NIH HHS R01 HL146745NIAAA NIH HHS R01 AA028406NICHD NIH HHS R01 HD086765NICHD NIH HHS R01 HD112102NIH HHS R01AA028406NIH HHS R01HD086765NIH HHS R01HD112102NIH HHS R01HL146745
6 · The paper itself

Abstract

Noninvasive monitoring of cardiac development can potentially prevent cardiac anomalies in adulthood. Mouse models provide unique opportunities to study cardiac development and disease in mammals. However, high-resolution noninvasive functional analyses of murine embryonic cardiac models are challenging because of the small size and fast volumetric motion of the embryonic heart, which is deeply embedded inside the uterus. In this study, a real time volumetric optoacoustic spectroscopy (VOS) platform for whole-heart visualization with high spatial (100 µm) and temporal (10 ms) resolutions is developed. Embryonic heart development on gestational days (GDs) 14.5-17.5 and quantify cardiac dynamics using time-lapse-4D image data of the heart is followed. Additionally, spectroscopic recordings enable the quantification of the blood oxygenation status in heart chambers in a label-free and noninvasive manner. This technology introduces new possibilities for high-resolution quantification of embryonic heart function at different gestational stages in mammalian models, offering an invaluable noninvasive method for developmental biology.

Indexed as

HeartPhotoacoustic TechniquesAnimalsFemaleMicePregnancySpectrum Analysiscardiovascular imagingembryo developmentfunctional imagingheartoptoacoustic spectroscopy

Identifiers

PMID38526147
PMCPMC11165471
OpenAlexW4393145207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.